MedPath

New Jersey Regenerative Institute, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Autologous, Micro-fragmented Adipose Tissue for Meniscal Tears

Phase 2
Completed
Conditions
Tibial Meniscus Injuries
Osteoarthritis, Knee
First Posted Date
2018-10-22
Last Posted Date
2019-09-25
Lead Sponsor
New Jersey Regenerative Institute, LLC
Target Recruit Count
20
Registration Number
NCT03714659

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.